RESUMO
Endometrial stromal cells undergo endoplasmic reticulum (ER) stress and unfolded protein response (UPR) during the decidualization linked with the inflammation and angiogenesis processes. Considering VIP (vasoactive intestinal peptide) induces the decidualization program, we studied whether modulates the ER/UPR pathways to condition both processes for embryo implantation. When Human Endometrial Stromal Cell line (HESC) were decidualized by VIP we observed an increased expression of ATF6α, an ER stress-sensor, and UPR markers, associated with an increase in IL-1ß production. Moreover, AEBSF (ATF6α -inhibitor pathway) prevented this effect and decreased the expansion index in the in vitro model of implantation. VIP-decidualized cells also favor angiogenesis accompanied by a strong downregulation in thrombospondin-1. Finally, ATF6α, VIP and VPAC2-receptor expression were reduced in endometrial biopsies from women with recurrent implantation failures in comparison with fertile. In conclusion, VIP privileged ATF6α-pathway associated with a sterile inflammatory response and angiogenesis that might condition endometrial receptivity.
Assuntos
Fator 6 Ativador da Transcrição/metabolismo , Implantação do Embrião , Endométrio/fisiologia , Estresse do Retículo Endoplasmático/efeitos dos fármacos , Células Estromais/efeitos dos fármacos , Resposta a Proteínas não Dobradas , Peptídeo Intestinal Vasoativo/farmacologia , Fator 6 Ativador da Transcrição/genética , Adolescente , Adulto , Endométrio/efeitos dos fármacos , Feminino , Humanos , Prognóstico , Transdução de Sinais , Vasodilatadores/farmacologia , Adulto JovemRESUMO
BACKGROUND: Maternal antigen-presenting cells attracted to the pregnant uterus interact with trophoblast cells and modulate their functional profile to favour immunosuppressant responses. Non-neuronal cholinergic system is expressed in human cytotrophoblast cells and in immune cells with homeostatic regulatory functions. AIM: The aim of this work was to evaluate whether non-neuronal acetylcholine conditions maternal monocyte and DC migration and activation profiles. METHODS: We used an in vitro model resembling maternal-placental interface represented by the co-culture of human trophoblast cells (Swan-71 cell line) and monocytes or DC. RESULTS: When cytotrophoblast cells were treated with neostigmine (Neo) to concentrate endogenous acetylcholine levels, monocyte migration was increased. In parallel, high levels of IL-10 and decreased levels of TNF-α were observed upon interaction of maternal monocytes with trophoblast cells. This effect was synergized by Neo and was prevented by atropine, a muscarinic acetylcholine receptor antagonist. Similarly, trophoblast cells increased the migration of DC independently of Neo treatment; however, enhanced IL-10 and MCP-1 synthesis in trophoblast-DC co-cultures with no changes in TNF-α and IL-6 was observed. In fact, there were no changes in HLA-DR, CD86 or CD83 expression. Finally, trophoblast cells treated with Neo increased the expression of two antigen-presenting cells attracting chemokines, MCP-1, MIP-1α and RANTES through muscarinic receptors, and it was prevented by atropine. CONCLUSIONS: Our present results support a novel role of acetylcholine synthesized by trophoblast cells to modulate antigen-presenting cell migration and activation favouring an immunosuppressant profile that contributes to immune homeostasis maintenance at the maternal-foetal interface.
Assuntos
Acetilcolina/metabolismo , Implantação do Embrião/imunologia , Placenta/metabolismo , Trofoblastos/citologia , Separação Celular/métodos , Técnicas de Cocultura , Feminino , Humanos , Inflamação/imunologia , Placenta/imunologia , Gravidez , Trofoblastos/imunologiaRESUMO
Sjögren's syndrome (SS) is a chronic autoimmune disease characterized by salivary and lacrimal gland dysfunction. Clinical observations and results from animal models of SS support the role of aberrant epithelial cell apoptosis and immune homeostasis loss in the glands as triggering factors for the autoimmune response. Vasoactive intestinal peptide (VIP) promotes potent anti-inflammatory effects in several inflammatory and autoimmune disease models, including the non-obese diabetic (NOD) mouse model of SS. With the knowledge that VIP modulates monocyte function through vasoactive intestinal peptide receptors (VPAC) and that immune homeostasis maintenance depends strongly upon a rapid and immunosuppressant apoptotic cell clearance by monocytes/macrophages, in this study we explored VPAC expression on monocytes from primary SS (pSS) patients and the ability of VIP to modulate apoptotic cell phagocytic function and cytokine profile. Monocytes isolated from individual pSS patients showed an increased expression of VPAC2 subtype of VIP receptors, absent in monocytes from control subjects, with no changes in VPAC1 expression. VPAC2 receptor expression could be induced further with lipopolysaccharide (LPS) in pSS monocytes and VIP inhibited the effect. Moreover, monocytes from pSS patients showed an impaired phagocytosis of apoptotic epithelial cells, as evidenced by reduced engulfment ability and the failure to promote an immunosuppressant cytokine profile. However, VIP neither modulated monocyte/macrophage phagocytic function nor did it reverse their inflammatory profile. We conclude that monocytes from pSS patients express high levels of VPAC2 and display a deficient clearance of apoptotic cells that is not modulated by VIP.
Assuntos
Apoptose , Citofagocitose/genética , Citofagocitose/imunologia , Monócitos/imunologia , Monócitos/metabolismo , Receptores Tipo II de Peptídeo Intestinal Vasoativo/genética , Síndrome de Sjogren/genética , Síndrome de Sjogren/imunologia , Adulto , Idoso , Estudos de Casos e Controles , Citofagocitose/efeitos dos fármacos , Regulação da Expressão Gênica/efeitos dos fármacos , Humanos , Lipopolissacarídeos/imunologia , Pessoa de Meia-Idade , Monócitos/efeitos dos fármacos , Receptores de Peptídeo Intestinal Vasoativo , Peptídeo Intestinal Vasoativo/farmacologia , Adulto JovemRESUMO
Successful embryo implantation occurs followed by a local inflammatory/T helper type 1 (Th1) response, subsequently redirected towards a tolerogenic predominant profile. The lack of control of this initial local inflammatory response may be an underlying cause of early pregnancy complications as recurrent spontaneous abortions (RSA). Considering that vasoactive intestinal peptide (VIP) mediates anti-inflammatory and tolerogenic effects in several conditions we hypothesized that VIP might contribute to tolerance towards trophoblast antigens during the early interaction of maternal leucocytes and trophoblast cells. In this study we investigated VIP/VPAC system activity and expression on maternal peripheral blood mononuclear cells (PBMCs) after interaction with immortalized trophoblast cells (Swan-71 cell line) as an in-vitro model of feto-maternal interaction, and we analysed whether it modulates maternal regulatory T cell (T(reg))/Th1 responses. We also investigated the contribution of the endogenous VIP/VPAC system to RSA pathogenesis. VIP decreased T-bet expression significantly, reduced monocyte chemotactic protein-1 (MCP-1) and nitrite production in co-cultures of PBMCs from fertile women with trophoblast cells; while it increased the frequency of CD4(+) CD25(+) forkhead box protein 3 (Foxp3)(+) cells, transforming growth factor (TGF)-ß expression and interleukin (IL)-10 secretion. These effects were prevented by VIP-specific antagonist. Interestingly, PBMCs from RSA patients displayed significantly higher T-bet expression, lower T(reg) frequency and lower frequency of VIP-producer CD4 lymphocytes after the interaction with trophoblast cells. Moreover, the patients displayed a significantly lower frequency of endometrial CD4(+) VIP(+) cells in comparison with fertile women. VIP showed a Th1-limiting and T(reg) -promoting response in vitro that would favour early pregnancy outcome. Because RSA patients displayed defects in the VIP/VPAC system, this neuropeptide could be a promising candidate for diagnostic biomarker or surrogate biomarker for recurrent spontaneous abortions.
Assuntos
Tolerância Imunológica/imunologia , Leucócitos/imunologia , Placenta/imunologia , Receptores de Peptídeo Intestinal Vasoativo/metabolismo , Peptídeo Intestinal Vasoativo/metabolismo , Adulto , Comunicação Celular/imunologia , Implantação do Embrião/imunologia , Perda do Embrião/genética , Perda do Embrião/imunologia , Endométrio/imunologia , Endométrio/metabolismo , Endométrio/patologia , Feminino , Humanos , Tolerância Imunológica/genética , Mediadores da Inflamação/imunologia , Mediadores da Inflamação/metabolismo , Leucócitos/metabolismo , Leucócitos Mononucleares/imunologia , Leucócitos Mononucleares/metabolismo , Placenta/metabolismo , Gravidez , Proteínas com Domínio T/genética , Proteínas com Domínio T/imunologia , Linfócitos T Reguladores/imunologia , Linfócitos T Reguladores/metabolismo , Trofoblastos/imunologia , Trofoblastos/metabolismoRESUMO
The spontaneous non-obese diabetic (NOD) mouse model of Sjögren's syndrome provides a valuable tool to study the onset and progression of both the autoimmune response and secretory dysfunction. Our purpose was to analyse the temporal decline of salivary secretion in NOD mice in relation to the autoimmune response and alterations in various signalling pathways involved in saliva secretion within each salivary gland. A progressive loss of nitric oxide synthase activity in submandibular and parotid glands started at 12 weeks of age and paralleled the decline in salivary secretion. This defect was associated with a lower response to vasoactive intestinal peptide in salivary flow rate, cAMP and nitric oxide/cGMP production. No signs of mononuclear infiltrates or local cytokine production were detectable in salivary glands in the time period studied (10-16 weeks of age). Our data support a disease model for sialadenitis in NOD mice in which the early stages are characterized by defective neurotransmitter-mediated signalling in major salivary glands that precedes the autoimmune response.
Assuntos
Autoimunidade/imunologia , Diabetes Mellitus Tipo 1/imunologia , Glândulas Salivares/imunologia , Sialadenite/imunologia , Animais , Autoanticorpos/sangue , GMP Cíclico/metabolismo , Citocinas/análise , Diabetes Mellitus Tipo 1/sangue , Diabetes Mellitus Tipo 1/patologia , Modelos Animais de Doenças , Feminino , Camundongos , Camundongos Endogâmicos BALB C , Camundongos Endogâmicos NOD , Óxido Nítrico Sintase/metabolismo , Glândula Parótida/imunologia , Glândula Parótida/patologia , Glândulas Salivares/patologia , Sialadenite/sangue , Sialadenite/patologia , Transdução de Sinais/imunologia , Glândula Submandibular/imunologia , Glândula Submandibular/patologia , Peptídeo Intestinal Vasoativo/imunologiaRESUMO
The non-obese diabetic (NOD) mouse model of autoimmune sialadenitis offers the possibility of studying the L-arginine/nitric oxide signaling pathway in salivary glands in basal and neurotransmitter-stimulated conditions and, thus, of analyzing the neural control of the secretory process in the target organ. The purpose of this study was to explore putative alterations in the activity and expression of nitric oxide synthase (NOS) in submandibular glands of NOD mice in relation to parotid glands and unrelated tissues. Here we report that NOD mice with incipient signs of secretory dysfunction presented a marked decrease in basal and vasoactive intestinal peptide (VIP)-stimulated NOS activity and a differential expression of NOS I in submandibular glands compared to control BALB/c mice. Similar alterations in NOS I were found in parotid glands but not in brain or spleen of NOD mice. No differences between NOD and controls appeared in NOS II and NOS III expression in any of the tissues studied.
Assuntos
Óxido Nítrico Sintase/metabolismo , Sialadenite/enzimologia , Síndrome de Sjogren/enzimologia , Glândula Submandibular/enzimologia , Amilases/metabolismo , Animais , Técnicas de Cultura , Feminino , Camundongos , Camundongos Endogâmicos BALB C , Camundongos Endogâmicos NOD , Óxido Nítrico Sintase Tipo I , Glândula Parótida/enzimologia , Isoformas de Proteínas/metabolismo , Saliva/enzimologia , Saliva/fisiologia , Glândula Submandibular/efeitos dos fármacos , Glândula Submandibular/metabolismo , Peptídeo Intestinal Vasoativo/farmacologiaRESUMO
Primary Sjögren Syndrome is a chronic autoimmune disease characterized by exocrine gland dysfunction. Here we present evidence of the activation of nitric oxide signaling cascade by circulating antibodies of patients with Sjögren Syndrome in rat submandibular glands. Constitutive nitric oxide synthase and cyclic GMP levels are modulated by Sjögren IgGs through the activation of muscarinic acetylcholine receptors on the glands. The effects are similar to those produced by the agonist carbachol and blocked by the antagonist atropine. The involvement of M1 subtype of muscarinic receptors is proposed since both a synthetic peptide homologous to an extracellular domain of M1 receptor and pirenzepine, a selective M1 antagonist, partially blocked the effects. We conclude that Sjögren Syndrome antibodies can activate nitric oxide signaling in submandibular glands by interacting with muscarinic acetylcholine receptors.
Assuntos
Autoanticorpos/farmacologia , Óxido Nítrico/metabolismo , Receptores Muscarínicos/imunologia , Receptores Muscarínicos/metabolismo , Síndrome de Sjogren/imunologia , Síndrome de Sjogren/metabolismo , Glândula Submandibular/imunologia , Glândula Submandibular/metabolismo , Adulto , Sequência de Aminoácidos , Animais , Autoanticorpos/sangue , Autoantígenos/genética , Feminino , Humanos , Imunoglobulina G/sangue , Imunoglobulina G/farmacologia , Pessoa de Meia-Idade , Dados de Sequência Molecular , Ratos , Ratos Wistar , Receptor Muscarínico M1 , Receptores Muscarínicos/genética , Transdução de SinaisRESUMO
We examined some of the signalling events in the negative modulation of isoproterenol-induced stimulation of contractility in rat isolated atria. Isoproterenol-mediated positive inotropic response is accompanied by the stimulation of nitric oxide synthase (NOS) and an increase in the production of cyclic GMP (cGMP). Inhibition of NOS and guanylate cyclase increased the dose-response curve of isoproterenol on contractility. Inhibitors of calcium flux or calcium calmodulin, but not of protein kinase C, abrogated these mechanisms. The existence of a modulatory negative inotropic-cyclic GMP-mediated mechanism limiting the effect of beta-adrenergic stimulation in myocardium is discussed.
Assuntos
Cardiotônicos/farmacologia , Contração Miocárdica , Miocárdio/metabolismo , Óxido Nítrico/fisiologia , Receptores Adrenérgicos beta/fisiologia , Animais , Função Atrial , GMP Cíclico/biossíntese , Átrios do Coração/enzimologia , Isoproterenol/farmacologia , Contração Miocárdica/efeitos dos fármacos , Miocárdio/enzimologia , Óxido Nítrico Sintase/metabolismo , Proteína Quinase C/metabolismo , Ratos , Receptores Adrenérgicos beta/efeitos dos fármacos , Estimulação QuímicaRESUMO
PURPOSE: The authors demonstrated that immunoglobulin G, present in the sera of patients with primary Sjögren syndrome (pSS), could recognize and activate muscarinic acetylcholine receptors (mAChRs) of rat exorbital acrimal gland. METHODS: Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE), immunoblotting, and radioligand binding and biologic assays were used to demonstrate autoantibodies against mAChRs. RESULTS: These autoantibodies recognized by means of SDS-PAGE and immunoblotting assay a band of approximately 70 kDa expressed on lacrimal gland membranes that comigrated with the peak of labeled mAChRs. Moreover, pSS IgG were able to inhibit, in an irreversible manner, the binding of [3H]quinuclidinyl benzilate to mAChRs of rat exorbital lacrimal glands and to simulate the biologic effect of mAChR agonists, because they trigger the activation of phosphoinositide turnover. Atropine and 4-diphenylacetoxy-N-methylpiperidine methiodide blocked the effect and carbachol mimicked it, confirming that the M3 subtype mAChRs mediated pSS IgG action. As control, IgG from sera of women without pSS gave negative results on immunoblotting, binding, and biologic assays, thus demonstrating the specificity of the reaction. CONCLUSIONS: Autoantibodies against mAChRs may be considered among the serum factors implicated in the pathophysiology of the development of pSS dry eyes.
Assuntos
Autoanticorpos/análise , Aparelho Lacrimal/imunologia , Receptores Muscarínicos/imunologia , Síndrome de Sjogren/imunologia , Adulto , Animais , Ligação Competitiva/efeitos dos fármacos , Relação Dose-Resposta a Droga , Eletroforese em Gel de Poliacrilamida , Feminino , Humanos , Immunoblotting , Imunoglobulina G/análise , Aparelho Lacrimal/efeitos dos fármacos , Antagonistas Muscarínicos/metabolismo , Antagonistas Muscarínicos/farmacologia , Fosfatidilinositóis/metabolismo , Quinuclidinil Benzilato/metabolismo , Ensaio Radioligante , Ratos , Ratos Wistar , Receptor Muscarínico M3 , Receptores Muscarínicos/metabolismoRESUMO
Experimental autoimmune myocarditis obtained in mice by immunization with heart antigens is characterized by the presence of lymphomononuclear infiltrates in atria and ventricles. Here we show the ability of soluble factors released by immune cells from mice immunized with heart antigens to decrease heart contractility in a similar way to a muscarinic agonist. These effects appear to be mediated by IFN-gamma since all of them could be blocked by an anti-IFN-gamma monoclonal antibody. Moreover, the negative inotropic effect induced by immune cell-conditioned media was blocked by atropine, confirming previous findings that IFN acts as a muscarinic agonist on isolated atria. The role of locally released cytokines and especially of IFN-gamma was also evaluated in infiltrated autoimmune myocarditis hearts; thus, the addition of monoclonal anti-IFN-gamma antibody reversed the decreased contractility characteristics of this model. We conclude that IFN released both systemically and locally by autoreactive T cells may contribute to the impaired cardiac function in this experimental model of autoimmune myocarditis.
Assuntos
Doenças Autoimunes/complicações , Modelos Animais de Doenças , Coração/fisiopatologia , Miocardite/imunologia , Animais , Linfócitos T CD4-Positivos/imunologia , Linfócitos T CD4-Positivos/metabolismo , Meios de Cultivo Condicionados/farmacologia , Interferon gama/fisiologia , Camundongos , Contração Miocárdica/efeitos dos fármacos , Contração Miocárdica/imunologia , Miocárdio/imunologia , Receptores Muscarínicos/fisiologia , Transdução de Sinais/efeitos dos fármacosRESUMO
IL-2 is known to have various effects outside the frame of the immune system and it could have a role as an autocrine modulatory agent in certain cardiac dysfunctions associated to inflammatory cell infiltration of the heart. In this study, by means of binding assays on cardiac membranes or by evaluating contractility and cAMP levels of isolated rat atria in the presence of IL-2, we demonstrate that IL-2 may indirectly stimulate beta-adrenergic-mediated function by triggering the presynaptic release of norepinephrine (NE) on isolated rat atria. Thus it reacts with cardiac tissue inducing a positive inotropic response that can be blocked by the beta-adrenergic antagonist propranolol but not by phentolamine. Binding of the beta-adrenergic antagonist CGP 12177 is not affected by IL-2. Furthermore, chemical sympathectomy with 6-hydroxydopamine (6-OHDA) prevents the inotropic effect of IL-2, while cocaine treatment sensitizes atria to IL-2, indicating that NE secretion is required, and that the beta-adrenergic effect of IL-2 is presynaptic. In addition, IL-2 mimics beta-adrenergic stimulation increasing cAMP synthesis. Colchicine inhibited cAMP stimulation as well as positive inotropism, and both effects of IL-2 were additive with isoproterenol. However, cAMP synthesis could only be partially blocked by propranolol, suggesting that IL-2 stimulated cAMP synthesis both by a direct, beta-adrenergic independent mechanism and by a beta-adrenergic dependent pathway. We conclude that IL-2 induces a positive inotropic response in isolated rat atria through two different pathways: an indirect activation of myocardial beta-adrenergic receptors by releasing catecholamines and a direct action by increasing the production of the second messenger cAMP.
Assuntos
Átrios do Coração/efeitos dos fármacos , Interleucina-2/farmacologia , Transdução de Sinais/fisiologia , Animais , Função Atrial , AMP Cíclico/biossíntese , Coração/efeitos dos fármacos , Coração/fisiologia , Átrios do Coração/metabolismo , Humanos , Masculino , Miocárdio/metabolismo , Ratos , Ratos Wistar , Receptores Adrenérgicos beta/metabolismo , Sistema Nervoso Simpático/fisiologiaRESUMO
Isolated congenital heart block may be associated with Primary Sjögren's Syndrome. In this work we demonstrated that IgG present in the sera of patients with Primary Sjögren's Syndrome (PSS) could bind and activate muscarinic acetylcholine receptors of rat neonatal atria. These antibodies were able to inhibit in a irreversible manner the binding of 3H-QNB to muscarinic cholinergic receptors of purified rat atria membranes. Moreover, IgG from PSS individuals could modify biological effects mediated by muscarinic cholinoceptors activation, i.e. decrease contractility and cAMP and increase phosphoinositide turnover and cGMP. Atropine blocked all of these effects and carbachol mimicked them; confirming muscarinic cholinergic receptors-mediated PSS IgG action. Neither binding nor biological effect were obtained using adult instead of neonatal rat atria. IgG from sera of normal women were not effective in the studied system. The prevalence of cholinergic antibody was 100% in PSS and was independent of Ro/SS-A and La/SS-B antibodies. It could be concluded that antibody against muscarinic cholinergic receptors may be another serum factor to be considered in the pathophysiology of the development of congenital heart block.
Assuntos
Receptores Muscarínicos/imunologia , Síndrome de Sjogren/imunologia , Adulto , Animais , Ligação Competitiva , AMP Cíclico/metabolismo , GMP Cíclico/metabolismo , Feminino , Humanos , Fosfatidilinositóis/metabolismo , Quinuclidinil Benzilato/metabolismo , RatosRESUMO
Herein we demonstrate by ELISA and immunoblotting the presence in the sera of chagasic patients of circulating autoantibodies against the third extracellular domain of human muscarinic acetylcholine receptors by using a synthetic peptide corresponding to the sequence 169-192 of the receptor. Immunoaffinity purified antipeptide antibodies displayed cardiac muscarinic activity as decreased contractility and cAMP production and increased cGMP levels. These effects were specifically blocked by the synthetic peptide and by atropine. A strong association between the existence of circulating autoantibodies and the presence of dysautonomia was shown, making these autoantibodies an appropriate marker of heart autonomic dysfunction.
Assuntos
Autoanticorpos/isolamento & purificação , Doença de Chagas/imunologia , Receptores Muscarínicos/imunologia , Adulto , Doenças do Sistema Nervoso Autônomo/imunologia , Biomarcadores , Doença de Chagas/sangue , AMP Cíclico , GMP Cíclico , Humanos , Pessoa de Meia-Idade , Contração Miocárdica , PeptídeosRESUMO
Hearts from mice hyperimmunized with cardiac tissue were studied to evaluate the expression and biological activity of muscarinic cholinergic receptors and immunoglobulin G deposits along the immunization period. Mice were sacrificed at 10 day intervals from the first injection up to day 100. Simultaneously, the activity of autoantibodies against muscarinic receptors on normal hearts was also examined in sera. Hearts with autoimmune myocarditis showed a muscarinic receptor-related dysfunction, with an impaired response to exogenous muscarinic agonists and a significant reduction in muscarinic binding sites, both effects being maximum at 40-50 days post-immunization. In addition, serum or immunoglobulin G from mice with myocarditis were able to interact with muscarinic acetylcholine receptors displaying a partial agonist effect. Autoimmune sera and immunoglobulin G reduced heart contractility while inhibited 3H-QNB binding to cardiac acetylcholine receptors in a concentration dependent manner showing the highest effects at days 40-50 and decreased progressively thereafter. The development of muscarinic receptor-related cardiac dysfunction may be associated with the presence of circulating antibodies having muscarinic receptor activity. These studies are of relevance to clinical conditions such as Chagas' disease, where immunological processes involving the cholinergic system are considered to cause cardiomyopathy.
Assuntos
Anticorpos/análise , Doenças Autoimunes/metabolismo , Miocardite/metabolismo , Miocárdio/metabolismo , Receptores Muscarínicos/imunologia , Receptores Muscarínicos/metabolismo , Animais , Imunofluorescência , Imunização , Camundongos , Camundongos Endogâmicos , Contração Miocárdica , Miocardite/fisiopatologia , Quinuclidinil Benzilato/metabolismoRESUMO
The contractile effect of histamine, as well as the H1 receptor population and H2 receptor-mediated cAMP production, were measured in cardiac tissue from control normal and autoimmune myocarditis mice. Histamine triggered positive chronotropy and negative inotropy at high concentrations in both control and autoimmune auricles, H2 receptors being the most important mediator of these responses. In contrast, in atria from autoimmune myocarditis mice, histamine at lower concentrations caused positive inotropy and negative chronotropy. These effects, not verified in the normal control atria, are mediated by H1 receptors. The expression of H2 and H1 receptors mediating the cardiac response to histamine was evaluated through histamine-stimulated cAMP level and binding of [3H] mephyramine, respectively. Both control and autoimmune myocardium were able to increase cAMP levels, an effect that was inhibited by H2 antagonist drug. The amount of cAMP was significantly higher in control myocardium than in those from autoimmune ones. Saturable binding of [3H] mephyramine occurs in autoimmune myocardium, with distinct high and low affinity binding sites. In control myocardium non-saturable binding was detected. These results suggest that H1 and H2 receptors coexist in heart from autoimmune myocarditis mice, whereas only H2 receptors are present in myocardium from control mice. The presence of H1 receptors in autoimmune myocardium could be an important factor in the regulation of its physiological behaviour.
Assuntos
Doenças Autoimunes/fisiopatologia , Histamina/farmacologia , Miocardite/fisiopatologia , Animais , AMP Cíclico/análise , Relação Dose-Resposta a Droga , Frequência Cardíaca/efeitos dos fármacos , Técnicas In Vitro , Camundongos , Contração Miocárdica/efeitos dos fármacos , Pirilamina/metabolismo , Receptores Histamínicos H1/fisiologia , Receptores Histamínicos H2/fisiologiaRESUMO
The possible role of altered humoral immunity in cardiac Chagas' disease was examined by analyzing the interaction of IgG and the corresponding F(ab')2 from Trypanosoma cruzi-infected patients with cardiac muscarinic cholinergic receptors (mAchR). Human chagasic IgG and its F(ab')2 simulated the agonist actions triggering the biological effects associated with cholinergic-mediated cellular transmembrane signals, i.e. stimulation of cGMP, inhibition of cAMP and a decrease in atrial contractility. Atropine blunted all of these effects while pertussis toxin prevented the inhibition of cAMP and contractility confirming the G-regulatory-protein-mediated response in the interaction of chagasic antibodies with cardiac mAchR. In addition, chagasic IgG and its F(ab')2 behaved as partial agonists activating the specific receptor and inhibiting in a noncompetitive manner the activity of an exogenous agonist (pilocarpine). Moreover, chagasic IgG immunoprecipitated the mAchR solubilized from cardiac membrane in a concentration-dependent fashion. By means of SDS-PAGE and immunoblotting analysis, chagasic serum was shown to recognize a band of approximately 75 kD. The electrophoretic studies of prelabeled immunoprecipitated proteins revealed a peak of [3H] propylbenzilylcholine mustard with an apparent molecular weight similar to that of mAchR, which disappeared in the presence of atropine. The presence of these antibodies in the serum of chagasic patients could explain the progressive receptor blockade in the parasympathetic branch of the cardiac autonomic nervous system associated with the cardioneuromyopathy described in the course of Chagas' disease.
Assuntos
Doença de Chagas/imunologia , Imunoglobulina G/imunologia , Testes de Precipitina , Receptores Muscarínicos/imunologia , Transdução de Sinais , Anticorpos/imunologia , AMP Cíclico/metabolismo , GMP Cíclico/metabolismo , Humanos , Imunoglobulina G/metabolismo , Pilocarpina/farmacologia , Fatores de TempoRESUMO
Two populations of histaminergic H1 receptors with distinct high and low affinity binding sites were characterized by the specific H1 receptor antagonist [3H]mepyramine in autoimmune myocardium. No saturable binding of the radiolabelled H1 antagonist was observed in normal myocardium. Reaction of autoimmune myocardium with specific H1 agonist (2-thiazolylethylamine (ThEA)) triggered positive inotropy and negative chronotropy, which were inhibited by mepyramine. Inhibitors of phospholipase C and protein kinase C attenuated both the inotropic and chronotropic effects of ThEA, suggesting the participation of phosphoinositide hydrolysis in this phenomenon. The latter was verified by measurement of polyphosphoinositide hydrolysis in autoimmune myocardium following the reaction of ThEA with histaminergic H1 receptors. We conclude that functional H1 histaminergic receptors could involve a distinctive mechanism operating in autoimmune myocardium as a result of cardiac antigen immunization.